Caricamento...
Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling
BACKGROUND: Anti TNF drugs have been widely used in rheumatoid arthritis (RA) but only 70 to 80 % of patients respond to this therapy. Exploring the mode of action of anti-TNF drugs remains important in order to improve the efficiency of the treatment and enhance our knowledge of inflammation. TNF-α...
Salvato in:
| Pubblicato in: | Arthritis Res Ther |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4774095/ https://ncbi.nlm.nih.gov/pubmed/26932562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0955-8 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|